These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6764105)
1. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci]. Kotake T Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of hormonally unresponsive prostatic carcinoma. deKernion JB; Lindner A Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779 [TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of prostatic carcinoma. Beckley S; Wajsman Z; Slack N; Mittelman A; Murphy GP Scand J Urol Nephrol Suppl; 1980; 55():151-62. PubMed ID: 6938019 [TBL] [Abstract][Full Text] [Related]
4. [Treatment for hormone-refractory or relapsing prostatic cancer]. Hirao Y; Ozono S; Okajima E Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492 [TBL] [Abstract][Full Text] [Related]
5. Results of trials of the USA National Prostatic Cancer Project. Elder JS; Gibbons RP Prog Clin Biol Res; 1985; 185A():221-42. PubMed ID: 3898131 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of prostatic carcinoma]. Wirth M; Altwein JE Urologe A; 1991 Jan; 30(1):17-24. PubMed ID: 2014582 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum]. Okumura S; Hasegawa J; Ohhara M; Kawamura N; Abe H; Yui Y; Kanamori S; Yoshida K; Nishimura T; Tomita M Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy: is it effective in treatment of prostatic cancer? Murphy GP Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094 [TBL] [Abstract][Full Text] [Related]
11. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326 [TBL] [Abstract][Full Text] [Related]
12. [Cytostatic therapy of prostatic carcinoma. Current status and personal results]. Nagel R; Leistenschneider W Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555 [TBL] [Abstract][Full Text] [Related]
13. Current treatment of advanced prostate cancer. Ismail M; Gomella LG Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for non-hormone refractory prostate cancer. Winquist E Can J Urol; 2006 Feb; 13 Suppl 1():67-70. PubMed ID: 16526986 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy in cancer of the prostate]. D'Acremont B; Gattegno B; Cohen L; Fiatte P; Lucaks B; Thibault P Ann Urol (Paris); 1990; 24(2):87-95. PubMed ID: 2190532 [TBL] [Abstract][Full Text] [Related]
16. Management of hormone refractory prostate cancer: current standards and future prospects. Oh WK; Kantoff PW J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323 [TBL] [Abstract][Full Text] [Related]
17. The case for early chemotherapy for the treatment of metastatic disease. Lucas A; Petrylak DP J Urol; 2006 Dec; 176(6 Pt 2):S72-5. PubMed ID: 17084173 [TBL] [Abstract][Full Text] [Related]
18. The role of systemic cytotoxic therapy for prostate cancer. Chang SS; Kibel AS BJU Int; 2009 Jan; 103(1):8-17. PubMed ID: 19040524 [TBL] [Abstract][Full Text] [Related]